IHL
MRNA icon

Investment House LLC’s Moderna MRNA Stock Holding History

Investment House LLC’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,815
Closed -$715K – 181
2021
Q4 		$715K Sell
2,815
-2,610
-48% -$763K 0.05% 128
2021
Q3 		$2.09M Buy
+5,425
New +$2M 0.15% 82

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Investment House LLC's MRNA Position: Q1 2022 in Review

Investment House LLC sold out of Moderna (MRNA) in Q1 2022, closing a stake of 2,815 shares — an estimated $715K sold.

Investment House LLC first reported a position in MRNA in Q3 2021 and held it in 2 quarters. The position peaked at $2.09M in Q3 2021. 1,006 funds tracked by Wall St. Rank hold MRNA as of Q1 2022.

  • Investment House LLC reported no remaining Moderna position as of Q1 2022 after selling out during the quarter.
  • Investment House LLC sold 2,815 Moderna shares in Q1 2022, an estimated $715K.
  • Investment House LLC first reported a position in Moderna in Q3 2021 and held it in 2 quarters.
  • Investment House LLC's Moderna position peaked at $2.09M in Q3 2021.
  • 1,006 funds tracked by Wall St. Rank held Moderna as of Q1 2022.

Based on Investment House LLC's 13F filing for Q1 2022, filed 14 Apr 2022.